Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks
- ML0064CP
- Pages: 25
- August 2017
- Total Views:1216
- Region : Global
- MarketLine
- Equity Research Report

Details
Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks
Summary
In recent years technological innovation has revolutionized almost all markets and industries. This combined with growing political uncertainty, slumps in consumer demand and shifting growth rates in developing economies has thrust many industries and markets into a brave new world.
Key Highlights
The North American pharmaceuticals market has performed poorly in recent years, due primarily to poor economic growth and moderate government austerity during the Obama administration.
In the future, market growth is expected to accelerate.
Johnson & Johnson leads the North American market, generating approximately $70bn in revenues in 2016.
Scope
Details market value and revenue growth rates, both historically and forecast.
Identifies the largest and most important companies in the market.
Compares the growth, in revenue and net profits, of each company over time.
Reviews how successfully each company utilizes its employees.
Considers share prices and their relative fluctuation over time.
Provides a breakdown of each company's performance, reviewing revenue, profit, share prices and the most recent quarterly performance.
Reasons to buy
What is the value of the market?
How has the value of the market changed historically?
How is the market forecast to perform in the future?
What are the leading companies in the market?
How does the performance of the leading companies compare?
How have their revenues and profits changed over time?
How does the share price growth of the leading companies compare?
How volatile are the share prices of the leading companies?
How has each leading company performed on a quarterly basis?
Table Of Content
Scope
Table of Contents
Introduction
Pharmaceuticals Market Segmentation: Market Value
Pharmaceuticals Market Segmentation: Value Growth
Top 10 Pharmaceuticals companies: Revenue
Top 10 Pharmaceuticals companies: Revenue Growth
Top 10 Pharmaceuticals companies: Revenue & Net Profit
Top 10 Pharmaceuticals companies: Profit
Top 10 Pharmaceuticals companies: Net Profit Margin
Top 10 Pharmaceuticals companies: Revenue Per Employee
Top 10 Pharmaceuticals companies: Share Price
Top 10 Pharmaceuticals companies: Revenue vs. Debt
Top 10 Pharmaceuticals companies: Companies
Appendix
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Gilead Sciences
Johnson & Johnson
Pfizer
Roche
Novartis
Amgen
Merck & Co.
Sanofi
AbbVie
AstraZeneca
Company Profile
Company Profile Title
Pharmaceuticals-North American Industry Leaders: Top 10 Company Financials Chartbooks
Summary
In recent years technological innovation has revolutionized almost all markets and industries. This combined with growing political uncertainty, slumps in consumer demand and shifting growth rates in developing economies has thrust many industries and markets into a brave new world.
Key Highlights
The North American pharmaceuticals market has performed poorly in recent years, due primarily to poor economic growth and moderate government austerity during the Obama administration.
In the future, market growth is expected to accelerate.
Johnson & Johnson leads the North American market, generating approximately $70bn in revenues in 2016.
Scope
Details market value and revenue growth rates, both historically and forecast.
Identifies the largest and most important companies in the market.
Compares the growth, in revenue and net profits, of each company over time.
Reviews how successfully each company utilizes its employees.
Considers share prices and their relative fluctuation over time.
Provides a breakdown of each company's performance, reviewing revenue, profit, share prices and the most recent quarterly performance.
Reasons to buy
What is the value of the market?
How has the value of the market changed historically?
How is the market forecast to perform in the future?
What are the leading companies in the market?
How does the performance of the leading companies compare?
How have their revenues and profits changed over time?
How does the share price growth of the leading companies compare?
How volatile are the share prices of the leading companies?
How has each leading company performed on a quarterly basis?
Scope
Table of Contents
Introduction
Pharmaceuticals Market Segmentation: Market Value
Pharmaceuticals Market Segmentation: Value Growth
Top 10 Pharmaceuticals companies: Revenue
Top 10 Pharmaceuticals companies: Revenue Growth
Top 10 Pharmaceuticals companies: Revenue & Net Profit
Top 10 Pharmaceuticals companies: Profit
Top 10 Pharmaceuticals companies: Net Profit Margin
Top 10 Pharmaceuticals companies: Revenue Per Employee
Top 10 Pharmaceuticals companies: Share Price
Top 10 Pharmaceuticals companies: Revenue vs. Debt
Top 10 Pharmaceuticals companies: Companies
Appendix
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Gilead Sciences
Johnson & Johnson
Pfizer
Roche
Novartis
Amgen
Merck & Co.
Sanofi
AbbVie
AstraZeneca